Skip to main content
. 2019 Apr 1;12(4):1478–1487.

Figure 3.

Figure 3

Comparison of diagnostic significance of miRNA-26a for all patients. A: Diagnostic value of plasmic and exosomal miRNA-26a in distinguishing HCC and HBV groups; B: Diagnostic value of plasmic and exosomal miRNA-26a in distinguishing HCC and hepatocirrhosis groups; C: Diagnostic value of plasmic and exosomal miRNA-26a in distinguishing hepatocirrhosis and HBV groups; D: Diagnostic value of plasmic and exosomal miRNA-29c in distinguishing HCC and HBV groups; E: Diagnostic value of plasmic and exosomal miRNA-29c in distinguishing HCC and hepatocirrhosis groups; F: Diagnostic value of plasmic and exosomal miRNA-29c in distinguishing hepatocirrhosis and HBV groups; G: Diagnostic value of plasmic and exosomal miRNA-21 in distinguishing HCC and HBV groups; H: Diagnostic value of plasmic and exosomal miRNA-21 in distinguishing HCC and hepatocirrhosis groups; I: Diagnostic value of plasmic and exosomal miRNA-21 in distinguishing hepatocirrhosis and HBV groups.